ASSESSMENT OF DOPAMINERGIC RESPONSE IN PARKINSONS-DISEASE USING THE APOMORPHINE TEST

被引:0
|
作者
MIRANDA, M [1 ]
SAEZ, D [1 ]
机构
[1] HOSP CLIN FELIX BULNES, UNIDAD NEUROL, SANTIAGO, CHILE
关键词
PARKINSON DISEASE; DOPAMINE APOMORPHINE; DIAGNOSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apomorfine is a potent dopaminergic agonist that quickly and predictably reverts parkinsonian symtomatology. In 32 patients (18 male) aged 45 to 83 years old (22 with idiopathic parkinsonism and 10 with parkinsonism of other causes), the dopaminergic response to apomorphine after domperidone administration was assessed using the digital skill test and Webster scale. Twenty patients with idiopathic parkinsonism and 1 with parkinsonism of other causes had a positive response to apomorphine. In 44% apomorphine had adverse effects. All patients with idiopathic parkinsonism and the only patient with parkinsonism of other causes with a positive apomorphine test had a good response to levodopa therapy. It is concluded that apomorphine test has a 95% positive predictive value for idiopathic parkinsonism and is a useful diagnostic tool.
引用
收藏
页码:326 / 329
页数:4
相关论文
共 50 条
  • [1] APOMORPHINE TEST FOR DOPAMINERGIC RESPONSIVENESS IN PATIENTS WITH PREVIOUSLY UNTREATED PARKINSONS-DISEASE
    GASSER, T
    SCHWARZ, J
    ARNOLD, G
    TRENKWALDER, C
    OERTEL, WH
    ARCHIVES OF NEUROLOGY, 1992, 49 (11) : 1131 - 1134
  • [2] DEFECATORY FUNCTION IN PARKINSONS-DISEASE - RESPONSE TO APOMORPHINE
    EDWARDS, LL
    QUIGLEY, EMM
    HARNED, RK
    HOFMAN, R
    PFEIFFER, RF
    ANNALS OF NEUROLOGY, 1993, 33 (05) : 490 - 493
  • [3] FORMULATING APOMORPHINE FOR PARKINSONS-DISEASE
    WOODCOCK, DA
    LANCET, 1995, 345 (8964): : 1569 - 1569
  • [4] SUBCUTANEOUS APOMORPHINE IN PARKINSONS-DISEASE
    POEWE, W
    KLEEDORFER, B
    GERSTENBRAND, F
    OERTEL, W
    LANCET, 1988, 1 (8591): : 943 - 943
  • [5] APOMORPHINE IN PATIENTS WITH PARKINSONS-DISEASE
    MUGUET, D
    BROUSSOLLE, E
    CHAZOT, G
    BIOMEDICINE & PHARMACOTHERAPY, 1995, 49 (04) : 197 - 209
  • [6] SUBCUTANEOUS APOMORPHINE IN PARKINSONS-DISEASE
    POLLAK, P
    CHAMPAY, AS
    HOMMEL, M
    PERRET, JE
    BENABID, AL
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (04): : 544 - 544
  • [7] INTRANASAL APOMORPHINE IN PARKINSONS-DISEASE
    KLEEDORFER, B
    TURJANSKI, N
    RYAN, R
    LEES, AJ
    MILROY, C
    STERN, GM
    NEUROLOGY, 1991, 41 (05) : 761 - 762
  • [8] COMPARISON OF MOTOR RESPONSE TO APOMORPHINE AND LEVODOPA IN PARKINSONS-DISEASE
    KEMPSTER, PA
    FRANKEL, JP
    STERN, GM
    LEES, AJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (11): : 1004 - 1007
  • [9] MOTOR RESPONSE TO APOMORPHINE AND LEVODOPA IN ASYMMETRIC PARKINSONS-DISEASE
    RODRIGUEZ, M
    LERA, G
    VAAMONDE, J
    LUQUIN, MR
    OBESO, JA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (05): : 562 - 566
  • [10] SUBLINGUAL APOMORPHINE AND PARKINSONS-DISEASE
    LEES, AJ
    MONTASTRUC, JL
    TURJANSKI, N
    RASCOL, O
    KLEEDORFER, B
    STPAUL, HP
    STERN, GM
    RASCOL, A
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (12): : 1440 - 1440